Key Takeaways
- Q1 2026 results from CoreWeave arrive May 7 following the closing bell
- Analysts project revenue surpassing $1.97 billion, reflecting more than 100% annual growth
- Options market suggests CRWV stock could swing 18.71% after earnings release
- Jefferies boosted price target to $160 while reaffirming Buy recommendation
- Year-to-date gains of 75% powered by significant contracts with Meta and Jane Street
CoreWeave is scheduled to unveil its first-quarter 2026 financial results this Thursday, May 7, following the market’s close. Shares have surged approximately 75% during the current year, hovering near $125 as the earnings announcement approaches.
CoreWeave, Inc. Class A Common Stock, CRWV
Analyst projections point toward quarterly revenue of approximately $1.97 billion, representing more than a doubling compared to the same period last year. The Street’s consensus estimate anticipates a per-share loss of roughly $0.91, expanding from the $0.60 deficit recorded in the first quarter of 2025.
The options market indicates potential volatility of around 18.71% in either direction once results are published. This substantial expected range underscores the considerable uncertainty surrounding the company’s near-term performance.
During the fourth quarter of 2025, CoreWeave delivered year-over-year revenue expansion of 110%, reaching $1.6 billion. The company achieved $5 billion in annualized revenue faster than most cloud infrastructure providers. However, profit margins registered just 6%, pressured by substantial investments in data center infrastructure.
Company guidance for the current quarter calls for revenue landing between $1.9 billion and $2 billion. Leadership also anticipates adjusted operating income ranging from $0 to $40 million, with margins hitting their annual low point due to a capital expenditure program totaling $6–$7 billion.
Major Contract Wins Drive Momentum
April proved exceptionally productive for CoreWeave’s business development efforts. The firm secured a $21 billion expanded agreement with Meta to deliver AI cloud infrastructure extending through December 2032. Jane Street simultaneously increased its commitment to approximately $6 billion while injecting an additional $1 billion equity investment into CoreWeave.
Jefferies analyst Brent Thill elevated his price objective to $160 from $120 before the earnings event, maintaining his Buy stance. Thill suggested these April agreements could elevate CoreWeave’s remaining performance obligations beyond $95 billion, compared with $67 billion at the close of 2025.
The company’s existing order backlog totals $66.8 billion. Virtually all computing capacity for 2026 has already been committed to customers.
Financing Concerns Remain a Key Factor
Supporting this aggressive expansion has required substantial capital. CoreWeave finalized an $8.5 billion delayed draw term loan facility last month. Over the trailing twelve months, the company has raised approximately $28 billion through combined equity offerings and debt instruments.
Long-term debt obligations reached $14.7 billion as of December 31, 2025, compared to $5.5 billion twelve months prior. Interest expense during Q4 escalated to $388 million from $149 million in the corresponding year-ago quarter.
This debt burden is anticipated to impact first-quarter financial performance. CoreWeave forecasts interest expense between $510–$590 million for the period.
The Zacks forecasting system does not project an earnings surprise this quarter. CRWV has fallen short of consensus predictions in three of its most recent four reporting periods, with an average negative deviation of 72.2%.
Nevertheless, nine among the ten largest AI model developers currently utilize CoreWeave’s infrastructure platform. In April, the business finalized a computing agreement with Anthropic to power Claude AI systems, with capacity scheduled to become operational later this year.
CoreWeave anticipates margin progression from low single-digit percentages in Q1 to low double-digit levels by the fourth quarter of 2026 as capacity utilization increases and revenue scales against predominantly fixed operational costs.
The consensus price target from Wall Street analysts stands at $133.21 for CRWV, supported by 11 Buy recommendations and four Hold ratings.
